Reduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection by blocking the epidermal growth factor receptor (EGFR) pathway. - Han Y; Kim S; Park T; Hwang H; Park S; Kim J; Pyun J-c; Lee M (Microbiology spectrum, 2024)